Patient-reported perceptions of brexanolone in the treatment of postpartum depression: A qualitative analysis.

Brexanolone rapidly and sustainably reduced symptoms of PPD and was well-received by patients. Despite significant barriers to use, women who received treatment with brexanolone advocated for its availability as well as increased awareness of PPD.